Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 2412156, 12 pages
https://doi.org/10.1155/2018/2412156
Research Article

Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration

1Department of Physical Chemistry, A.M. Butlerov Institute of Chemistry, Kazan Federal University, Kremlevskaya 18, Kazan 420008, Russia
2ZPTI-Subdivision, FIC KazanSC of RAS, Sibirsky Tract 10/7, Kazan 420029, Russia
3Institute of Engineering, Kazan Federal University, Kremlevskaya 18, Kazan 420008, Russia

Correspondence should be addressed to A. V. Gerasimov; ur.ufpk@vomisareg.rednaxela

Received 15 August 2017; Revised 11 November 2017; Accepted 23 November 2017; Published 10 January 2018

Academic Editor: Sami M. Nazzal

Copyright © 2018 L. S. Usmanova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Loira-Pastoriza, J. Todoroff, and R. Vanbever, “Delivery strategies for sustained drug release in the lungs,” Advanced Drug Delivery Reviews, vol. 75, pp. 81–91, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Patton, C. S. Fishburn, and J. G. Weers, “The lungs as a portal of entry for systemic drug delivery,” in Proceedings of the American Thoracic Society, vol. 1, pp. 338–344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. W.-H. Lee, C.-Y. Loo, D. Traini, and P. M. Young, “Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges,” Asian Journal of Pharmaceutical Sciences, vol. 10, no. 6, pp. 481–489, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. Patton, “Mechanisms of macromolecule absorption by the lungs,” Advanced Drug Delivery Reviews, vol. 19, no. 1, pp. 3–36, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Chrystyn, “Is total particle dose more important than particle distribution?” Respiratory Medicine, vol. 91, pp. 17–19, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. A. F. Tena and P. C. Clarà, “Deposition of Inhaled Particles in the Lungs,” Archivos de Bronconeumología (English Edition), vol. 48, no. 7, pp. 240–246, 2012. View at Publisher · View at Google Scholar
  7. R. U. Agu, M. I. Ugwoke, M. Armand, R. Kinget, and N. Verbeke, “The lung as a route for systemic delivery of therapeutic proteins and peptides,” Respiratory Research, vol. 2, no. 4, pp. 198–209, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Rudt and R. H. Müller, “In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. I. effect of analytical parameters, particle size and particle concentration,” Journal of Controlled Release, vol. 22, no. 3, pp. 263–271, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Lipinski, “Poor aqueous solubility - An industry wide problem in drug discovery,” American Pharmaceutical Review, vol. 5, no. 3, pp. 82–85, 2002. View at Google Scholar · View at Scopus
  10. Y. Kawabata, K. Wada, M. Nakatani, S. Yamada, and S. Onoue, “Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications,” International Journal of Pharmaceutics, vol. 420, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Onoue, Y. Kojo, Y. Aoki, Y. Kawabata, Y. Yamauchi, and S. Yamada, “Physicochemical and Pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability,” Drug Metabolism and Pharmacokinetics, vol. 27, no. 4, pp. 379–387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Baghel, H. Cathcart, and N. J. O'Reilly, “Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs,” Journal of Pharmaceutical Sciences, vol. 105, no. 9, pp. 2527–2544, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Bühler, Polyvinylpyrrolidone excipients for pharmaceuticals. Povidone, crospovidone and copovidone, Springer-Verlag, Berlin, Germany, 2005.
  14. V. G. Kadajji and G. V. Betageri, “Water soluble polymers for pharmaceutical applications,” Polymer, vol. 3, no. 4, pp. 1972–2009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Paradkar, A. A. Ambike, B. K. Jadhav, and K. R. Mahadik, “Characterization of curcumin-PVP solid dispersion obtained by spray drying,” International Journal of Pharmaceutics, vol. 271, no. 1-2, pp. 281–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Ambike, K. R. Mahadik, and A. Paradkar, “Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations,” Pharmaceutical Research, vol. 22, no. 6, pp. 990–998, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. P. Patel, D. J. Patel, D. B. Bhimani, and J. K. Patel, “Physicochemical characterization and dissolution study of solid dispersions of furosemide with polyethylene glycol 6000 and polyvinylpyrrolidone k30,” Dissolution Technologies, vol. 15, no. 3, pp. 17–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Paudel, J. Van Humbeeck, and G. Van Den Mooter, “Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone),” Molecular Pharmaceutics, vol. 7, no. 4, pp. 1133–1148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Frizon, J. D. O. Eloy, C. M. Donaduzzi, M. L. Mitsui, and J. M. Marchetti, “Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods,” Powder Technology, vol. 235, pp. 532–539, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Saluja, A. Mehanna, R. Panicucci, and E. Atef, “Hydrogen bonding: Between strengthening the crystal packing and improving solubility of three haloperidol derivatives,” Molecules, vol. 21, no. 6, article no. 719, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. C. L. Ng, S.-E. Lee, J.-K. Lee et al., “Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers,” International Journal of Pharmaceutics, vol. 512, no. 1, pp. 314–321, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Zhi, H. Fang, C. Bao et al., “The immunotoxicity of graphene oxides and the effect of PVP-coating,” Biomaterials, vol. 34, no. 21, pp. 5254–5261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Escamilla-Rivera, M. Uribe-Ramírez, S. González-Pozos, O. Lozano, S. Lucas, and A. De Vizcaya-Ruiz, “Protein corona acts as a protective shield against Fe3O4-PEG inflammation and ROS-induced toxicity in human macrophages,” Toxicology Letters, vol. 240, no. 1, pp. 172–184, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. P. R. Byron and J. S. Patton, “Drug delivery via the respiratory tract,” Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 7, no. 1, pp. 49–75, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Hussain, J. J. Arnold, M. A. Khan, and F. Ahsan, “Absorption enhancers in pulmonary protein delivery,” Journal of Controlled Release, vol. 94, no. 1, pp. 15–24, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. J. Singleton, “The use of Polyvinylpyrrolidone as a plasma volume expander in preventing or combating shock,” Texas Reports on Biology and Medicine, vol. 11, pp. 138–143, 1953. View at Google Scholar
  27. B. V. Robinson, F. M. Sullivan, J. F. Borzelleca, and S. L. Schwartz, PVP – a critical review of the kinetics and toxicology of Polyvinylpyrrolidone (Povidone), Lewis Publishers, Chelsea, 1990.
  28. R. P. Kumar and A. Abraham, “PVP- coated naringenin nanoparticles for biomedical applications – In vivo toxicological evaluations,” Chemico-Biological Interactions, vol. 257, pp. 110–118, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Wu and J. W. McGinity, “Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.,” AAPS PharmSciTech [electronic resource], vol. 2, no. 4, p. 24, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. P. M. Oliveira, B. N. Matos, P. A. Pereira et al., “Microparticles prepared with 50–190 kDa chitosan as promising non-toxic carriers for pulmonary delivery of isoniazid,” Carbohydrate Polymers, vol. 174, pp. 421–431, 2017. View at Publisher · View at Google Scholar
  31. J. Broadhead, S. K. Edmond Rouan, and C. T. Rhodes, “The spray drying of pharmaceuticals,” Drug Development and Industrial Pharmacy, vol. 18, no. 11-12, pp. 1169–1206, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. Y.-C. Tseng, B. Linehan, K. J. Ng et al., “Cardiovascular safety pharmacology studies in dogs enabled for a poorly soluble molecule using spray-dried dispersion: Impact on lead selection,” International Journal of Pharmaceutics, vol. 512, no. 1, pp. 137–146, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Watanabe, M. Okada, Y. Kudo et al., “Differences in the effects of fibrous and particulate titanium dioxide on alveolar macrophages of Fischer 344 rats,” Journal of Toxicology and Environmental Health, Part A. Current Issues, vol. 65, no. 15, pp. 1047–1060, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Gharsallaoui, G. Roudaut, O. Chambin, A. Voilley, and R. Saurel, “Applications of spray-drying in microencapsulation of food ingredients: an overview,” Food Research International, vol. 40, no. 9, pp. 1107–1121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. D. A. Miller, D. Ellenberger, and M. Gil, “Spray-Drying Technology,” in Formulating Poorly Water Soluble Drugs, vol. 22 of AAPS Advances in the Pharmaceutical Sciences Series, pp. 437–525, Springer International Publishing, Cham, 2016. View at Publisher · View at Google Scholar
  36. X. Li, N. Anton, C. Arpagaus, F. Belleteix, and T. F. Vandamme, “Nanoparticles by spray drying using innovative new technology: the Büchi Nano Spray Dryer B-90,” Journal of Controlled Release, vol. 147, no. 2, pp. 304–310, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. S. H. Lee, D. Heng, W. K. Ng, H. K. Chan, and R. B. H. Tan, “Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy,” International Journal of Pharmaceutics, vol. 403, no. 1-2, pp. 192–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. B. D. Nandiyanto and K. Okuyama, “Progress in developing spray-drying methods for the production of controlled morphology particles: from the nanometer to submicrometer size ranges,” Advanced Powder Technology, vol. 22, no. 1, pp. 1–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Beck-Broichsitter, C. Schweiger, T. Schmehl, T. Gessler, W. Seeger, and T. Kissel, “Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery,” Journal of Controlled Release, vol. 158, no. 2, pp. 329–335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Jabłczyńska, M. Janczewska, A. Kulikowska, and T. R. Sosnowski, “Preparation and characterization of biocompatible polymer particles as potential nanocarriers for inhalation therapy,” International Journal of Polymer Science, vol. 2015, Article ID 763020, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Sou, M. P. McIntosh, L. M. Kaminskas, R. J. Prankerd, and D. A. V. Morton, “Designing a Multicomponent Spray-Dried Formulation Platform for Pulmonary Delivery of Biomacromolecules: The Effect of Polymers on the Formation of an Amorphous Matrix for Glassy State Stabilization of Biomacromolecules,” Drying Technology, vol. 31, no. 13-14, pp. 1451–1458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Sou, L. M. Kaminskas, T.-H. Nguyen, R. Carlberg, M. P. McIntosh, and D. A. V. Morton, “The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 83, no. 2, pp. 234–243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Bonfiglio, R. C. King, T. V. Olah, and K. Merkle, “The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds,” Rapid Communications in Mass Spectrometry, vol. 13, no. 12, pp. 1175–1185, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Ono, F. Hirayama, H. Arima, K. Uekama, and J. H. Rytting, “Model analysis for oral absorption of a drug/cyclodextrin complex involving competitive inclusion complexes,” Journal of Inclusion Phenomena and Macrocyclic Chemistry, vol. 44, no. 1-4, pp. 93–96, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. V. Gerasimov, M. A. Ziganshin, V. V. Gorbatchuk, and L. S. Usmanova, “Formation of solid dispersion of PEG-1000 with phenacetin according to differential scanning calorimetry,” Der Pharma Chemica, vol. 5, no. 6, pp. 149–155, 2013. View at Google Scholar · View at Scopus
  46. A. Galukhin, M. A. Khelkhal, A. Gerasimov et al., “Mn-catalyzed oxidation of heavy oil in porous media: kinetics and some aspects of the mechanism,” Energy & Fuels, vol. 30, no. 9, pp. 7731–7737, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. A. V. Gerasimov, M. A. Ziganshin, and V. V. Gorbatchuk, “A calorimetric study of the formation of phenacetin solid dispersions with PEG-1400 and pluronic F127,” World Applied Sciences Journal, vol. 24, no. 7, pp. 920–927, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. M. A. Ziganshin, A. A. Bikmukhametova, A. V. Gerasimov, V. V. Gorbatchuk, S. A. Ziganshina, and A. A. Bukharaev, “The effect of substrate and air humidity on morphology of films of L-leucyl-L-leucine dipeptide,” Protection of Metals and Physical Chemistry of Surfaces, vol. 50, no. 1, pp. 49–54, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. M. A. Ziganshin, A. V. Gerasimov, S. A. Ziganshina et al., “Thermally induced diphenylalanine cyclization in solid phase,” Journal of Thermal Analysis and Calorimetry, vol. 125, no. 2, pp. 905–912, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Gerasimov, M. Varfolomeev, M. Ziganshin et al., “Thermodynamics of dissolution and infrared-spectroscopy of solid dispersions of phenacetin,” Journal of Advanced Pharmaceutical Technology & Research, vol. 7, no. 1, pp. 6–12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. M. A. Varfolomeev, K. V. Zaitseva, I. T. Rakipov, B. N. Solomonov, and W. Marczak, “Speed of sound, density, and related thermodynamic excess properties of binary mixtures of butan-2-one with C1-C4 n-alkanols and chloroform,” Journal of Chemical & Engineering Data, vol. 59, no. 12, pp. 4118–4132, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Jarunglumlert and K. Nakagawa, “Spray drying of casein aggregates loaded with β-carotene: influences of acidic conditions and storage time on surface structure and encapsulation efficiencies,” Drying Technology, vol. 31, no. 13-14, pp. 1459–1465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. U. Bhardwaj and D. J. Burgess, “A novel USP apparatus 4 based release testing method for dispersed systems,” International Journal of Pharmaceutics, vol. 388, no. 1-2, pp. 287–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Sollohub and K. Cal, “Spray drying technique: II. Current applications in pharmaceutical technology,” Journal of Pharmaceutical Sciences, vol. 99, no. 2, pp. 587–597, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. W. Adamson, Physical Chemistry of Surfaces, John Wiley & Sons, NJ, USA, 5th edition, 1990.
  56. G. Zhang, A. David, and T. S. Wiedmann, “Performance of the vibrating membrane aerosol generation device: Aeroneb micropump nebulizer™,” Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, vol. 20, no. 4, pp. 408–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. H. Wen, K. R. Morris, and K. Park, “Study on the interactions between polyvinylpyrrolidone (PVP) and acetaminophen crystals: partial dissolution pattern change,” Journal of Pharmaceutical Sciences, vol. 94, no. 10, pp. 2166–2174, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. M. T. Zafarani-Moattar and Z. Khoshsima, “Measurement and correlation of density and viscosity of polyvinylpyrrolidone solutions in alcohols at different temperatures,” The Journal of Chemical Thermodynamics, vol. 40, no. 11, pp. 1569–1574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. J. C. Callahan, G. W. Cleary, M. Elefant, G. Kaplan, T. Kensler, and R. A. Nash, “Equilibrium moisture content of pharmaceutical excipients,” Drug Development and Industrial Pharmacy, vol. 8, no. 3, pp. 355–369, 1982. View at Publisher · View at Google Scholar · View at Scopus
  60. B. C. Hancock, S. L. Shamblin, and G. Zografi, “Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures,” Pharmaceutical Research, vol. 12, no. 6, pp. 799–806, 1995. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. B. Kim, H. J. Song, and I. Y. Park, “Refinement of the structure of naproxen, (+)-6-methoxy-α-methyl-2-naphthaleneacetic acid,” Archives of Pharmacal Research, vol. 10, no. 4, pp. 232–238, 1987. View at Publisher · View at Google Scholar · View at Scopus
  62. X. Yuan, T.-X. Xiang, B. D. Anderson, and E. J. Munson, “Hydrogen bonding interactions in amorphous indomethacin and its amorphous solid dispersions with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl acetate) studied using 13c solid-state NMR,” Molecular Pharmaceutics, vol. 12, no. 12, pp. 4518–4528, 2015. View at Publisher · View at Google Scholar · View at Scopus
  63. W. C. Hinds, Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles, John Wiley & Sons, NJ, USA, 2 nd edition, 1999.
  64. D. E. Potts, D. C. Levin, and S. A. Sahn, “Pleural fluid pH in parapneumonic effusions,” CHEST, vol. 70, no. 3, pp. 328–331, 1976. View at Publisher · View at Google Scholar · View at Scopus
  65. M. C. Houston, “Pleural fluid pH: Diagnostic, therapeutic, and prognostic value,” The American Journal of Surgery, vol. 154, no. 3, pp. 333–337, 1987. View at Publisher · View at Google Scholar · View at Scopus